Biosynthesis of immunosuppressant tacrolimus: a review / 生物工程学报
Chinese Journal of Biotechnology
;
(12): 3095-3110, 2023.
Artigo
em Chinês
| WPRIM
| ID: wpr-1007947
ABSTRACT
Tacrolimus (FK506) is a 23-membered macrolide with immunosuppressant activity that is widely used clinically for treating the rejection after organ transplantation. The research on tacrolimus production was mainly focused on biosynthesis methods, within which there are still some bottlenecks. This review summarizes the progress made in tacrolimus biosynthesis via modification of metabolic pathways and control of fermentation process, with the hope to address the technical bottlenecks for tacrolimus biosynthesis and improve tacrolimus production by fermentation engineering and metabolic engineering.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Tacrolimo
/
Macrolídeos
/
Fermentação
/
Imunossupressores
/
Antibacterianos
Idioma:
Chinês
Revista:
Chinese Journal of Biotechnology
Ano de publicação:
2023
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS